Clinical trial
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00002914 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002914 |
|---|---|
| Title | Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract |
| Official title | PHASE II STUDY OF PIRITREXIM IN ADVANCED CARCINOMA OF THE UROTHELIUM |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | piritrexim |
| Enrollment | 40 |
| Start date | Jul 15, 1997 |
| Primary completion | Jun 1, 2001 |
| Completion | Mar 1, 2004 |
| First posted | Aug 11, 2004 |
| Last update posted | Jun 22, 2023 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: